Advertisement

Topics

Companies Related to "Drug Keytruda Help Block Melanoma Return" [Most Relevant Company Matches] RSS

05:36 EDT 23rd May 2018 | BioPortfolio

Here are the most relevant search results for "Drug Keytruda Help Block Melanoma Return" found in our extensive corporate database of over 50,000 company records.

Showing "Drug Keytruda Help Block Melanoma Return" Companies 1–25 of 3,700+

Relevant

AIM at Melanoma

AIM at Melanoma, founded in memory of Charlie Guild, who died of melanoma at the age of 26, is the largest international melanoma foundation focused on melanoma research, patient advocacy, legislation, education and awareness. The foundation supports melanoma research efforts by hosting international research forums and is helping to create the first melan...


H&R Block Bank

H&R Block is guided by a mission that is understood, embraced and pursued by the entire organization: "To help our clients achieve their financial objectives by serving as their tax and financial partner." As part of the H&R Block family of companies, the H&R Block Bank furthers that corporate mission by offering needed banking products and services that are simple and affordable to our customers....

Polynoma LLC

Malignant melanoma is the most serious form of skin cancer. An estimated 200,000 new cases of melanoma are diagnosed annually around the world, with about 76,000 in the United States alone. The melanoma market is estimated to be in excess of US$1 billion, with the U.S. and Europe being the primary markets.


Provectus Biopharmaceuticals, Inc.

Provectus Biopharmaceuticals specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer and cancers of the liver....

Melanoma Research Alliance (MRA)

MRA is a public charity formed in 2007 under the auspices of the Milken Institute, with the generous founding support of Debra and Leon Black. Due to the ongoing support of its founders, 100% of every dollar MRA raises goes to support its melanoma research program. The organization is poised to build on recent momentum in the field, accelerating the pace o...

Melanoma Research Alliance

MRA is a public charity formed in 2007 under the auspices of the Milken Institute, with the generous founding support of Debra and Leon Black. MRA is poised to build on recent momentum in the field, accelerating the pace of scientific discovery and translation in order to eliminate suffering and death due to melanoma. MRA’s ability to fund wide-ran...

The Melanoma Research Alliance

MRA is a public charity formed in 2007 under the auspices of the Milken Institute, with the generous founding support of Debra and Leon Black. MRA is poised to build on recent momentum in the field, accelerating the pace of scientific discovery and translation in order to eliminate suffering and death due to melanoma. MRA’s ability to fund wide-ranging ...

InCytu Incorporated

InCytu is a privately held biotherapeutic company with its primary operations located in Rhode Island. The Company is targeting its Cellarium vaccine at treating late stage melanoma tumors while gathering promising preliminary data using the Cellarium to treat other cancers. InCytu has established a manufacturing facility for creating Cellarium devices in ...

Provectus Pharmaceuticals, Inc.

Provectus Pharmaceuticals specializes in developing oncology and dermatology therapies. Its lead oncology agent, PV-10, is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer and metastatic liver cance...

Angstrom Pharmaceuticals Incorporated

Ångstrom Pharmaceuticals, Inc. was formed in 1996 to add a new dimension to drug discovery. It is committed to discovering drugs that block the docking of an extracellular regulatory protein (ligand) to its receptor found on the outside of a cell – when this event is responsible for initiating a disease state. Receptors can be identified that trigger several intractable diseases including cance...

SolaranRx, Inc.

SolaranRx, Inc. is developing a platform of new therapies and companion imaging agents for the treatment of metastatic melanoma. This merger between therapeutics and diagnostics—often referred to as theranostics—constitutes a new level of personalized medicine for treating metastatic melanoma. SolaranRx seeks to improve treatment and patientsâ€...

SolaranRx

SolaranRx, Inc. is developing a platform of new therapies and companion imaging agents for the treatment of metastatic melanoma. This merger between therapeutics and diagnostics—often referred to as theranostics—constitutes a new level of personalized medicine for treating advanced melanoma. SolaranRx seeks to improve treatment and patients’...

MoleSafe USA

MoleSafe USA is the world's most advanced melanoma screening program designed to protect you and your family from the deadly effects of melanoma skin cancer. MoleSafe is a state-of-the-art procedure involving the digital imaging, archiving and diagnosis of moles and other suspicious lesions. MoleSafe digital images have been used at Memorial Sloan Kettering Cancer Center for skin cancer studie...

Chemical Block

The informational company Chemical Block (CB) was started up by graduates of the Lomonosov Moscow State University in 1999. Most of the CB principal employees previously occupied high positions in various affiliates of the Russian Academy of Sciences and have a sound professional background. The company's policy focuses on implementing the idea of an integrated data search system to reveal and col...

Polynoma, Inc.

Polynoma, Inc. is an oncology-focused biotechnology company based in San Diego, the United States of America. Polynoma’s lead product candidate is the therapeutic vaccine POL 103A for the treatment of melanoma. The Phase 3 trial of POL 103A was initiated based on two randomized, controlled Phase 2 trials that showed statistically significant efficacy ...

Community Drug Compounding Center

Community Drug, an independent provider of pharmaceutical products and services, has been located in the Greenfield-Squirrel Hill area of Pittsburgh, PA for almost 85 years. David Hairhoger, R.Ph., owner and Chief Pharmacist of Community Drug, along with his staff of pharmacists, pharmacy technicians and store employees continue to provide traditional pharmaceutical care to their many patients. Ho...

Sequoia Pharmaceuticals, Inc.

Sequoia Pharmaceuticals discovers and develops revolutionary new treatments for viral diseases including HIV/AIDS and HCV-induced hepatitis with a focus on the growing global problem of drug-resistant infectious diseases. Most anti-infective drugs were designed to block the most prevalent form of a pathogen. Those drugs are doomed to become obsolete due to the emergence of drug-resistant mutations...

Odyssey Thera, Inc.

Odyssey Thera Inc. is a drug discovery company that has developed a global cellular pharmacology strategy for the identification of safe and effective medicines for a wide spectrum of human diseases. The company’s mission is to transform the predictability and speed of drug discovery through an understanding of the entire scope of drug action, prior to clinical trials. The company’s initial pr...

Athenix

Athenix is an E-Solutions provider leveraging the power of Internet-based technologies to enhance business and organizational processes. We work collaboratively with our clients throughout the entire project lifecycle. From strategy to design and implementation to measuring outcomes, we partner to identify and realize opportunities that increase return on investment, enhance productivity, and buil...

Chloraseptic(R) Allergen Block

Waismann Method

Performed in a hospital intensive care unit, the Waismann Method involves the administration of medications to reverse the physiological dependence on opiates while the symptoms of withdrawal are addressed. During the procedure, the patient experiences minimal conscious withdrawal, and will be able to return home within days. Seventy-five percent of the prescription drug dependent patients who ar...

Gene Tools LLC

Gene Tools is the sole commercial supplier for research quantities of Morpholino antisense oligos world-wide. Our Morpholino oligos are the premier tools for gene knockdown in developmental biology labs and are the best gene-silencing reagents for cells in culture. Morpholino oligos are short chains of Morpholino subunits comprised of a nucleic acid base, a morpholine ring and a non-ionic phosphor...

Melanoma Foundation of New England

Melanoma Research Foundation

BioCryst Pharmaceuticals

BioCryst Pharmaceuticals, Inc. designs, optimizes and develops novel drugs that block key enzymes essential for viral, cardiovascular and oncologic disease processes. By integrating multiple scientific disciplines - biology, crystallography, medicinal chemistry and computer modeling - BioCryst effectively uses structure-based drug design to discover and develop small-molecule pharmaceuticals.


More From BioPortfolio on "Drug Keytruda Help Block Melanoma Return"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks